BIO
Price
$248.85
Change
+$3.87 (+1.58%)
Updated
Apr 23 closing price
Capitalization
9.79B
7 days until earnings call
ILMN
Price
$76.25
Change
+$1.90 (+2.56%)
Updated
Apr 23 closing price
Capitalization
21.09B
14 days until earnings call
Ad is loading...

BIO vs ILMN

Header iconBIO vs ILMN Comparison
Open Charts BIO vs ILMNBanner chart's image
Bio-Rad Laboratories
Price$248.85
Change+$3.87 (+1.58%)
Volume$272.44K
Capitalization9.79B
Illumina
Price$76.25
Change+$1.90 (+2.56%)
Volume$1.66M
Capitalization21.09B
BIO vs ILMN Comparison Chart
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. ILMN commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Buy and ILMN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BIO: $248.85 vs. ILMN: $76.25)
Brand notoriety: BIO: Not notable vs. ILMN: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 71% vs. ILMN: 63%
Market capitalization -- BIO: $9.79B vs. ILMN: $21.09B
BIO [@Medical Specialties] is valued at $9.79B. ILMN’s [@Medical Specialties] market capitalization is $21.09B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileILMN’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • ILMN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIO and ILMN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 5 TA indicator(s) are bullish while ILMN’s TA Score has 6 bullish TA indicator(s).

  • BIO’s TA Score: 5 bullish, 3 bearish.
  • ILMN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ILMN is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical Specialties) experienced а +1.48% price change this week, while ILMN (@Medical Specialties) price change was +3.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

BIO is expected to report earnings on Jul 24, 2025.

ILMN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ILMN($21.1B) has a higher market cap than BIO($9.79B). ILMN has higher P/E ratio than BIO: ILMN (49.50) vs BIO (3.64). BIO YTD gains are higher at: -24.249 vs. ILMN (-42.939). ILMN has higher annual earnings (EBITDA): -608M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. ILMN (1.05B). BIO has less debt than ILMN: BIO (1.41B) vs ILMN (2.26B). ILMN has higher revenues than BIO: ILMN (4.5B) vs BIO (2.67B).
BIOILMNBIO / ILMN
Capitalization9.79B21.1B46%
EBITDA-654.76M-608M108%
Gain YTD-24.249-42.93956%
P/E Ratio3.6449.507%
Revenue2.67B4.5B59%
Total Cash1.61B1.05B152%
Total Debt1.41B2.26B62%
FUNDAMENTALS RATINGS
BIO vs ILMN: Fundamental Ratings
BIO
ILMN
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9293
PRICE GROWTH RATING
1..100
6465
P/E GROWTH RATING
1..100
7893
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ILMN's Valuation (77) in the Biotechnology industry is in the same range as BIO (79) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to BIO’s over the last 12 months.

ILMN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BIO (100) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to BIO’s over the last 12 months.

BIO's SMR Rating (92) in the Medical Specialties industry is in the same range as ILMN (93) in the Biotechnology industry. This means that BIO’s stock grew similarly to ILMN’s over the last 12 months.

BIO's Price Growth Rating (64) in the Medical Specialties industry is in the same range as ILMN (65) in the Biotechnology industry. This means that BIO’s stock grew similarly to ILMN’s over the last 12 months.

BIO's P/E Growth Rating (78) in the Medical Specialties industry is in the same range as ILMN (93) in the Biotechnology industry. This means that BIO’s stock grew similarly to ILMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOILMN
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP0.930.04
+4.42%
CNS Pharmaceuticals Inc.
DLNG3.410.04
+1.19%
Dynagas LNG Parners LP
GL122.791.11
+0.91%
Globe Life
AMN18.170.13
+0.72%
AMN Healthcare Services
MTUS13.14-0.08
-0.61%
Metallus

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been loosely correlated with RVTY. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if BIO jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+1.58%
RVTY - BIO
64%
Loosely correlated
+1.46%
RGEN - BIO
58%
Loosely correlated
+1.78%
A - BIO
56%
Loosely correlated
+2.13%
TMO - BIO
56%
Loosely correlated
-0.71%
QDEL - BIO
52%
Loosely correlated
+5.19%
More

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
+2.56%
RVTY - ILMN
58%
Loosely correlated
+1.46%
BIO - ILMN
53%
Loosely correlated
+1.58%
A - ILMN
53%
Loosely correlated
+2.13%
BRKR - ILMN
52%
Loosely correlated
+2.52%
IQV - ILMN
50%
Loosely correlated
+2.40%
More